Is the Flexible GnRH Antagonist Protocol Better Suited for Fresh eSET Cycles?
Elias M. Dahdouh, Francisco L.A.F. Gomes, Louis R. Granger, Belina Carranza‐Mamane, Faez Faruqi, Tiao Virirak Kattygnarath, Pierre St-Michel
Abstract
Open-access reader
Elias M. Dahdouh, Francisco L.A.F. Gomes, Louis R. Granger, Belina Carranza‐Mamane, Faez Faruqi, Tiao Virirak Kattygnarath, Pierre St-Michel
Abstract
Open-access reader
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Medicine, Antagonist, Agonist, In vitro fertilisation, Hormone antagonist, Andrology, Gonadotropin-releasing hormone, Embryo transfer